Shenzhen, China

Xianpeng Zhang

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Appotronics Corporation Limited, Ylx Corporation. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xianpeng Zhang. Retrieved from https://idiyas.com/inventor/xianpeng-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.6

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Xianpeng Zhang

Introduction: Xianpeng Zhang, a visionary inventor hailing from Shenzhen, China, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Zhang's latest patents include a cutting-edge AI-powered healthcare device designed to revolutionize patient care, as well as a sustainable energy solution that aims to tackle environmental challenges.

Career Highlights: With a career spanning over two decades, Xianpeng Zhang has established himself as a leading figure in the tech industry. His innovative spirit and dedication to pushing boundaries have led to the development of numerous pioneering technologies.

Collaborations: Zhang has collaborated with top research institutions and leading tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Xianpeng Zhang's relentless pursuit of innovation and his passion for creating technologies that make a difference have solidified his reputation as a trailblazing inventor in the global tech community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…